The committee really helpful to extend the usage of original Spikevax vaccine and Spikevax bivalent Original/Omicron BA.1 as a booster dose in youngsters aged 6 to eleven years. The committee advisable changing the conditional advertising authorisation of the COVID-19 vaccine Jcovden to a normal advertising authorisation. An outline of all of the COVID-19 vaccines authorised in the EU is obtainable on EMA_s web site. The agenda of the December 2022 CHMP meeting is published on EMA's webpage. Minutes of the November 2022 CHMP assembly will probably be published in the coming weeks. Key figures from the December 2022 CHMP assembly are represented in the graphic under. This product was designated as an orphan drugs throughout its development. Orphan designations are reviewed by EMA's Committee for Orphan Medicinal Products (COMP) at the time of approval to find out whether or not the information available to this point permits sustaining the medicine_s orphan standing and granting the drugs ten years of market exclusivity.
发表于 2025-9-24 22:55:06
收藏